Hypertension Clinical Trials in Beijing
16 recruitingBeijing, China
Showing 1–16 of 16 trials
Recruiting
Phase 3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1153 locationsNCT07064473
Recruiting
Phase 3
A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option
Hypertension, Pulmonary
Actelion280 enrolled43 locationsNCT05179876
Recruiting
Phase 3
A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)
Hypertension
Eli Lilly and Company974 enrolled101 locationsNCT06948422
Recruiting
Phase 3
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2
Hypertension
Eli Lilly and Company487 enrolled99 locationsNCT06952530
Recruiting
Phase 3
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1
HypertensionOverweight or Obesity
Eli Lilly and Company487 enrolled99 locationsNCT06948435
Recruiting
Phase 3
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Chronic Kidney Disease and Hypertension
AstraZeneca5,000 enrolled753 locationsNCT06742723
Recruiting
Not Applicable
Prospective Exploratory Study on the Comprehensive Application Effectiveness of Exercise Prescription Decision Support Tools in the Management of Patients With "Four Highs" (Hypertension, Hyperglycemia, Hyperlipidemia, Hyperuricemia)
HypertensionHyperuricemiaHyperglycemia+2 more
China National Center for Cardiovascular Diseases100 enrolled1 locationNCT07400549
Recruiting
National Registry and Cohort Study of Pulmonary Vascular Disease
Pulmonary Arterial Hypertension
Nanjing First Hospital, Nanjing Medical University1,000 enrolled13 locationsNCT05368467
Recruiting
Not Applicable
Study on the Treatment of Nonthrombotic Obstructive Pulmonary Hypertension
Pulmonary HypertensionFibrosing Mediastinitis
Beijing Chao Yang Hospital48 enrolled1 locationNCT06980584
Recruiting
China Pulmonary Vascular Disease Intervention Diagnosis and Management Study-right Heart Catheterization
Pulmonary Embolism (Diagnosis)Pulmonary HypertensionPulmonary Arterial Hypertension+1 more
China-Japan Friendship Hospital10,000 enrolled1 locationNCT06954727
Recruiting
Phase 3
A Phase III Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension in China
Open Angle GlaucomaOcular Hypertension
Santen Pharmaceutical Co., Ltd.338 enrolled25 locationsNCT06666855
Recruiting
the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary Hypertension
Pulmonary HypertensionChronic Thromboembolic Pulmonary HypertensionPulmonary Arterial Hypertension Associated With Schistosomiasis (Disorder)
Chinese Pulmonary Vascular Disease Research Group4,000 enrolled1 locationNCT02061787
Recruiting
Chinese PE Multimodality Imaging Artificial Intelligence Study
Pulmonary EmbolismChronic Thromboembolic Pulmonary HypertensionChronic Thromboembolic Pulmonary Disease
China-Japan Friendship Hospital1,500 enrolled1 locationNCT06526468
Recruiting
Change-a Multi-center Chronic Thromboembolic Pulmonary Hypertension （CTEPH） Database in China
Chronic Thromboembolic Pulmonary Hypertension
China-Japan Friendship Hospital1,500 enrolled1 locationNCT05311072
Recruiting
CHASE Registry of Patients With Pulmonary Hypertension Receiving Targeted Therapy
Pulmonary Hypertension
Chinese Pulmonary Vascular Disease Research Group5,000 enrolled1 locationNCT06135909
Recruiting
Safety and Efficacy of Balloon Pulmonary Angioplasty in China
Chronic Thromboembolic Pulmonary Hypertension
Chinese Pulmonary Vascular Disease Research Group200 enrolled2 locationsNCT04206852